A Bioequivalence Study of Two Different Dosage Form of Genakumab

NCT06451848 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
178
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.